These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38326043)

  • 1. [Analyses of the risk factors for the progression of primary antiphospholipid syndrome to systemic lupus erythematosus].
    Chen SY; Zheng MM; Wang CH; Jiang H; Li J; Zhao JL; Zhao Y; Hou RH; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):170-175. PubMed ID: 38326043
    [No Abstract]   [Full Text] [Related]  

  • 2. Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis.
    Bundhun PK; Soogund MZS; Huang F
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):212. PubMed ID: 29879927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients.
    Medina G; Vera-Lastra O; Barile L; Salas M; Jara LJ
    Lupus; 2004; 13(1):11-6. PubMed ID: 14870912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylserine-Dependent Anti-prothrombin Antibodies as a Key Predictor for Systemic Lupus Erythematosus in Patients with Primary Antiphospholipid Syndrome: A retrospective longitudinal cohort study.
    Wei J; Fujieda Y; Fujita Y; Ogata Y; Hisada R; Kono M; Amengual O; Kato M; Atsumi T
    Mod Rheumatol; 2024 Aug; ():. PubMed ID: 39187460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.
    Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M
    Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?
    Freire PV; Watanabe E; dos Santos NR; Bueno C; Bonfá E; de Carvalho JF
    Clin Rheumatol; 2014 Mar; 33(3):349-53. PubMed ID: 24420722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?
    Signorelli F; Balbi GGM; Bonfá E; Borba EF; Andrade DCO
    Lupus; 2021 Oct; 30(11):1732-1738. PubMed ID: 34292093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.
    Moss KE; Isenberg DA
    Rheumatology (Oxford); 2001 Aug; 40(8):863-7. PubMed ID: 11511754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
    Tincani A; Andreoli L; Chighizola C; Meroni PL
    Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome.
    Kapitany A; Tarr T; Gyetvai A; Szodoray P; Tumpek J; Poor G; Szegedi G; Sipka S; Kiss E
    Ann N Y Acad Sci; 2009 Sep; 1173():545-51. PubMed ID: 19758197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    Reshetnyak T; Nurbaeva K; Ptashnik I; Kudriaeva A; Belogurov A; Lila A; Nasonov E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to Domain I β
    Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
    Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations.
    Palli E; Kravvariti E; Tektonidou MG
    Front Immunol; 2019; 10():487. PubMed ID: 30930907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.